HC Wainwright Reaffirms Buy Rating for Zentalis Pharmaceuticals (NASDAQ:ZNTL)
Zentalis Pharmaceuticals (NASDAQ:ZNTL – Get Free Report)‘s stock had its “buy” rating restated by equities research analysts at HC Wainwright in a note issued to investors on Thursday,Benzinga reports. They presently have a $10.00 price target on the stock. HC Wainwright’s target price indicates a potential upside of 452.49% from the stock’s current price. A […]
Zentalis Pharmaceuticals (NASDAQ:ZNTL – Get Free Report)‘s stock had its “buy” rating restated by equities research analysts at HC Wainwright in a note issued to investors on Thursday,Benzinga reports. They presently have a $10.00 price target on the stock. HC Wainwright’s target price indicates a potential upside of 452.49% from the stock’s current price. A […]
